In breast cancer, overexpression of ENO1 may be associated with lower metastasis-free survival (17, 23), and poor prognosis, whereas its silencing suppresses proliferation and autophagy, while inducing apoptosis in pancreatic cells (24). Here, ENO1 is linked to breast carcinoma.